This Article Full Text (PDF) All Versions of this Article: 0269881108093271v1 23/6/686    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cader, S Articles by Matthews, P. Search for Related Content PubMed PubMed Citation Articles by Cader, S Articles by Matthews, P. Social Bookmarking                         What's this?

Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis

Centre for Functional Magnetic Resonance Imaging of the Brain, University of Oxford, UK; Institute of Psychiatry, King's College London, London, UK

J Palace

Department of Clinical Neurology, Radcliffe Infirmary, Oxford, UK

PM Matthews

Centre for Functional Magnetic Resonance Imaging of the Brain, University of Oxford, UK; Department of Clinical Neurosciences and GSK Clinical Imaging Centre, Imperial College London and Hammersmith Hospital, London, UK paul.m.matthews{at}gsk.com

Abstract

The aim of this study is to define mechanisms underlying the pharmacological effects of brain cholinesterase inhibition on cognitive function in patients with multiple sclerosis (MS). Both a Stroop task and an N-back task were used to probe the changes in brain activity using functional magnetic resonance imaging (fMRI) in a single (investigator)-blind, crossover treatment design studying 15 patients with multiple sclerosis (12 relapsing remitting, 3 secondary progressive) taking rivastigmine (4.5 mg po bid) and domperidone (10 mg po qd) or domperidone alone. Administration of rivastigmine increased Stroop functional magnetic resonance imaging activation in the right inferior frontal gyrus for the Stroop task (P < 0.05, corrected). Incremental functional magnetic resonance imaging activation with progressively greater N-back task difficulty was enhanced by rivastigmine in prefrontal and parietal cortical regions (P < 0.01, ANOVA). Functional connectivity analysis of the N-back functional magnetic resonance imaging data based on correlations between pair-wise interregional activations showed increased connectivity between left to right prefrontal, anterior cingulate to left prefrontal and right parietal to right prefrontal regions with rivastigmine (P < 0.05, corrected). Although there were no statistically significant changes in the neuropsychological task performance with rivastigmine in this small study, 11 of 15 patients showed improvements, whereas only 4 of 15 patients showed decline in performance (P = 0.07). With regard to the previous data, these findings suggest different patterns of brain response to lower dose acute and higher dose chronic administration of rivastigmine in patients with multiple sclerosis. They showed that rivastigmine enhances the prefrontal function and alters the functional connectivity associated with cognition. We interpret this as evidence for greater efficiency of brain information transfer that should increase confidence in a potentially beneficial clinical therapeutic effect.

Key Words: acetylcholine • cognition • fMRI • multiple sclerosis • neuropsychology

This version was published on August 1, 2009

Journal of Psychopharmacology, Vol. 23, No. 6, 686-696 (2009)
DOI: 10.1177/0269881108093271


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?